Cheryl Maley
Chief Executive Officer
Starpharma
Cheryl Maley is Chief Executive Officer of Starpharma, an Australian biotechnology company advancing dendrimer based therapies for patients with unmet needs, including cancer. With 25+ years in pharma and 20 in leadership across Novartis and AbbVie, she has led innovation, commercial strategy, and growth in Australia, Asia, and global markets.
At Novartis, Cheryl served as Country Head and President of Novartis Philippines and as General Manager, Oncology for Australia and New Zealand, where she oversaw the launch of multiple products in oncology, neurology, cardiovascular and immunology.
A champion of equity in STEMM, she builds diverse teams, embeds inclusion into strategy, and expands sponsorship and visibility pathways for women. Cheryl is committed to investing in skills, mentoring, and early career opportunities to transform leadership and talent pathways across the STEMM ecosystem.
SESSIONS
Day 1
9:40
C-Suite leadership panel: Transforming pathways for equity in STEMM
Reframing equity and inclusion as critical to workforce and leadership strategies
Practical frameworks for executive leaders to create visibility and actively sponsor high-potential women into critical, strategic decision-making roles
Future-proofing the pipeline – How to attract, upskill and mentor the next generation of leaders amid AI disruption? What human capabilities must we recruit and develop for right now?
Moderator: Natasha Mandie, Managing Director and CEO, EM Advisory
Cheryl Maley, Chief Executive Officer, Starpharma
Brooke Mills, Co-founder & Chief Executive Officer, Astraea Technologies
Associate Professor Michael Ben-Meir, Chief Executive Officer, Royal Flying Doctor Service Victoria
Erin Ashton, AI Enablement Leader, EY